Lavasept, Konzentrat

7680504450704 CH-50445 Konzentrat

Associated product:

LAVASEPT conc fl 100 ml
Lavasept, Konzentrat
Lavasept, Konzentrat
Lavasept, Konzentrat
1 / 3
google

Article details

Package size
100
Selling units
100
Measure
ml
Galenic form
Konzentrat
Galenic group
Tinkturen/Desinfektion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
17/06/2021
Summary of Product Characteristics
Français
17/06/2021
Summary of Product Characteristics
Italien
17/06/2021

Detailed composition

Substance Quantity Type Category
(N/A)
200.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Authorization holder

B. Braun Medical AG

6204 Sempach

Authorization information

Swissmedic authorization number
50445
Drug name
Lavasept, Lösung zur Anwendung auf der Haut
Galenic form
LSKU
ATC Code
D08AC05
Authorization status
Z
Dispensing category
B
First authorization
17/12/1991
Authorization expiration date
31/12/9999
IT Number
10.09.1.
Domain
Human medicine
Field of application
Lokales Antiseptikum

Package details

Description (FR)
LAVASEPT conc fl 100 ml
Description (DE)
LAVASEPT Konz Fl 100 ml
Market launch
17/12/1991
Narcotic (BTM)
No

Other package sizes (5)

LAVASEPT conc 5 amp 2 ml
None None
GTIN: 7680504450896
View
LAVASEPT sol fl 100 ml
100 ML
GTIN: 7680504450971
View
LAVASEPT sol fl 250 ml
250 ML
GTIN: 7680504451008
View
LAVASEPT sol fl 500 ml
500 ML
GTIN: 7680504451190
View
LAVASEPT sol fl 1000 ml
1000 ML
GTIN: 7680504451275
View